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Abstract: Idiopathic epilepsy (IE) is one of the most common neurologic disorder in dogs. The aim of this study 
was to describe the clinical data of dogs with IE in Japan and to search for predisposing factors of IE for further 
investigation. Medical records and clinical information of dogs diagnosed with IE at 2 referral centers between 
April 2013 and March 2016 were retrospectively reviewed. It was conducted according to the consensus state-
ment published by International Veterinary Epilepsy Task Force. A total of 70 dogs were used with a median 
(range) weight of 5.15 (1.85–79.85) kg and age at initial epileptic seizure onset of 4.2 (0.3–11.8) years. Forty-
four dogs were male, and 26 were female. Toy Poodles were over-represented in the present study indicating that 
this breed may be predisposed to IE and would be a candidate for gene study to elucidate the cause of IE in dogs.
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Introduction
Epilepsy is one of the most common chronic neurological 
disorder in both dogs and humans. The prevalence has been 
reported to be 0.6-0.75% in dogs1,2). Recently, International 
Veterinary Epilepsy Task Force (IVETF) was organized and 
series of a consensus statement on canine epilepsy were 
published in 20153-10). About half of the dogs with epilepsy is 
classified as idiopathic epilepsy (IE). IE is defined as epilepsy 
of predominantly genetic or presumed genetic origin and in 
which there are no gross neuroanatomical or neuropatho-
logical abnormalities nor other relevant underlying diseases 
causing seizure activity4). Today, there are 3 genes reported 
to be associated with IE in specific breeds11-13) but the cause 
of IE remains unknown. A further genetic study is needed 
to elucidate the cause of IE.  There is no cure for IE and 
most of the dogs with this disease need to be medicated with 
antiepileptic drug (AED) for its life to prevent an epileptic 
seizure. Despite adequate AEDs, 20–30% of the epileptic 
dogs will remain inadequate seizure control14-16).  Seizures 
have an impact on both affected animals and the owners of 
the animals17-19). There are several epidemiological studies on 
epilepsy in dogs20-23). The epidemiological distribution varies 
from region to region. There is only one epidemiological 
study from Japan on epilepsy in dogs recently reported22). 
Further study on IE is required to understand the disease 
in Japan. Therefore, the aim of this study is to describe 
the clinical data of dogs with IE in Japan and to search for 
predisposing factors of IE for further investigation.
Materials and Methods
The medical record of dogs diagnosed with IE at the Neu-
rology service of the Azabu University Veterinary Teaching Corresponding author: Miyoko Saito (e-mail: msaito@azabu-u.ac.jp)
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Hospital (AUVTH) and clinical information of the dogs 
diagnosed with IE at Companion Animal Medical Imaging 
Center (CamiC) sent to Neurology service of the AUVTH 
between April 2013 and March 2016 were retrospectively 
reviewed. The diagnosis of IE was made according to the 
IVETF consensus statement5). Information collected included 
signalment (body weight, the age of initial epileptic seizure 
onset, sex, breed), and seizure type. According to the IVETF 
consensus statement4), seizure type was classified to focal 
epileptic seizure (FES), generalized epileptic seizure (GES) 
and focal epileptic seizure evolving into generalized epileptic 
seizure (FEvG). For analysis of breed as a risk factor for IE, 
the control population consisted of all dogs evaluated at the 
AUVTH between April 2013 and March 2016, that did not 
have diagnosed with IE at the Neurology service.
Further investigation was performed in dogs diagnosed at 
Neurology service of the AUVTH. These include the duration 
of the seizure, whether the dog had ever had an episode of 
cluster seizure (CS) or status epilepticus (SE), autonomic 
sign during the seizure, prodrome, post-ictal phenomenon, 
short-term (6 months) therapeutic outcome and QOL of the 
dogs and their owners. According to the IVETF consensus 
statement8), the dogs were evaluated their achievement of 
therapeutic outcome to the following 3 levels; primary goal 
(seizure free or seizure frequency decreased to 1/3 and seizure 
frequency is < 0.3 times/month), secondary goal (become 
cluster seizure / status epilepticus free or relatively decreased 
seizure frequency or decreased seizure severity) and no re-
sponder (other than primary goal and secondary goal). The 
owners were asked to answer to the questionnaire17) at their 
visit to AUVTH or sent the questionnaire by mail. 
The Kruskal-Wallis test was used to evaluate differences 
in the duration of the seizure among seizure types. Breed 
distributions of dogs with IE (the breed that had 5 or more 
dogs diagnosed with IE) were compared with breed distribu-
tion of the control dogs examined at the AUVTH. P values, 
odds ratios (ORs) and their 95% confidence intervals (CIs) 
were calculated for each comparison made. P values were 
calculated by means of Fisher exact tests. The value of P < 
0.05 was considered significant. Statistical analyses were 
performed using JMP®7.0.1 (SAS Institute).
Results
Twenty-eight dogs were diagnosed with IE at Neurology 
service of AUVTH and the clinical information of 42 dogs 
diagnosed with IE at CamiC was sent to Neurology service 
of the AUVTH. A total of 70 dogs with IE were used in this 
study with a median (range) weight of 5.15 (1.85–79.85) kg 
and age of initial epileptic seizure onset of 4.2 (0.3–11.8) 
years. Forty-four dogs were male (27 castrated), and 26 were 
female (15 spayed).  The breeds included 16 Toy Poodles, 
10 Chihuahuas, 6 Miniature Dachshunds, 4 each of Italian 
Greyhounds and mixed-breed dogs, 3 each of Cavalier King 
Charles Spaniels and Yorkshire Terriers, 2 each of American 
Cocker Spaniels, Beagles, Pekingeses, Boston Terriers, Pom-
eranians and Miniature Schnauzers and 1 each of Pembroke 
Welsh Corgi, Cairn Terriers, Shih-Tzu, Shetland Sheep Dog, 
Jack Russell Terrier, Shiba, Pug, Saint Bernard, Papillon, 
French Bulldog, Miniature Pinscher, Wire Fox Terrier. The 
4779 dogs examined at the AUVTH were included in the 
study as control dogs for analysis of breed as a risk factor 
for IE. Toy Poodles had a higher probability of having IE (P 
= 0.03; OR = 3.08; 95% CI, 1.24–7.64) compared with that 
of Chihuahuas (P = 0.80; OR = 0.44; 95% CI, 0.06–3.23) 
and Miniature Dachshunds (P = 0.73; OR = 1.13; 95% CI, 
0.43–2.99). Twenty-one (30 %) dogs were FES, 37 (53 %) 
were GES and 9 (13 %) were FEvG. Two (2.7 %) dogs had 
both GES and FEvG and 1 (1.3 %) dog’s seizure type was 
unknown. The median (range) duration of the seizure was 150 
(15–900) seconds. The Duration of seizure of each seizure 
type is summarized in Table 1. There were no significant dif-
ferences in duration of the seizure between 3 seizure types (P 
> 0.05). Fifty-seven percent and 39 % of the dogs had CS and 
Table 1 The Duration of seizure (seconds) of each 
seizure type (median, range)
Seizure type Duration of seizure (seconds)
FES (n = 10) 180 (15–900)
GES (n = 12) 135 (20–270)
FEvG (n = 7)   90 (25–150)
All cases (n = 29)* 150 (15–900)
*Twenty-nine seizures were analyzed from 28 dogs 
because 1 dog had 2 seizure type
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SE, respectively. Twenty-five percent of the dogs experienced 
both CS and SE. Autonomic signs were observed in 68 % of 
the dogs. Urination was the most frequently (50 %) observed 
autonomic sign.  Fourteen percent and 68 % of the dogs had 
prodrome and post-ictal phenomenon, respectively. The CS, 
SE, Autonomic signs, prodrome, and post-ictal phenomenon 
status of each seizure type is provided in Table 2. Twenty 
(71%) dogs were able to evaluate its therapeutic outcome. 
Sixty percent was on monotherapy whereas the remaining 40 
% was on two or more AEDs. Eight dogs were evaluated as 
the primary goal, 6 were the secondary goal and remaining 
6 were no responder. The AEDs, seizure frequency prior 
to and after starting AED, the therapeutic outcome of each 
dog is provided in Table 3. Seven owners responded to the 
questionnaire of QOL. The answers to the questionnaire are 
summarized in Table 4.
Table 2 The Cluster seizure (CS), status epilepticus (SE) status, autonomic 










CS 2 (20 %) 10 (83 %) 5 (71 %) 17 (57 %)
SE 4 (40 %) 5 (42 %) 2 (29 %)  11 (39 %)
CS + SE 1 (10 %) 5 (42 %) 1 (14 %) 6 (21 %)
Autonomic signs 3 (30 %) 11 (92 %) 6 (86 %) 20 (71 %)
Prodrome 1 (10 %) 3 (25 %) 0 (0 %) 4 (14 %)
Post-ictal phenomenon 4 (40 %) 9 (75 %) 6 (86%) 19 (68 %)
Table 3 The seizure type, AED, seizure frequency (times/month) prior to and after stating AED, the therapeutic 
outcome of each dog. The seizure frequency of the dog No.11 was not available, thus the therapeutic 
outcome was evaluated based on its seizure severity
Seizure frequency 
Dog No. Seizure type AED Prior After Therapuetic outcome
1 GES PB 1.3 0.3 secondary goal
2 GES ZNS, LEV 4 3.8 secondary goal
3 GES PB 3.1 0 Primary goal
4 GES LEV 0.2 0 Primary goal
5 GES PB, KBr,ZNS 0.5 1 No responder
6 GES PB, KBr, ZNS, LEV 0.5 2.2 No responder
7 FES KBr, ZNS, LEV 0.3 0 Primary goal
8 FES ZNS 1 0 Primary goal
9 FES ZNS 0.2 0.2 Primary goal
10 GES PB 0 0.8 No responder
11 FES ZNS, LEV, CLP NA NA secondary goal
12 FES PB, ZNS, LEV 2 6.7 No responder
13 FEvG PB, KBr, ZNS, LEV 1.8 2.4 No responder
14 GES+FEvG ZNS 0.9 0.83 secondary goal
15 FEvG PB several times 0 Primary goal
16 FEvG ZNS 2 0.3 secondary goal
17 GES PB, KBr, ZNS, LEV 4 10 No responder
18 FEvG ZNS 1.1 0 Primary goal
19 FES ZNS 1.6 0 Primary goal
20 GES ZNS 1 1.7 secondary goal
AED: PB, phenobarbital; KBr, potassium bromide; ZNS, Zonisamide; LEV, Levetiracetam; CLP, clorazepate.
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Table 4 The answers to the questionnaire17)
Score 1 2 3 4 5 6 7
Seizure severity and frequency 1–5 (strongly agree–strongly disagree)
In the last 3 months, the frequency of the fits in my dog was acceptable 2 4 1 0 0 - -
In the last 3 months, the severity of the fits in my dog was acceptable 3 3 1 0 0 - -
In the last 3 months, overall, the fits in my dog are managed successfully 3 2 2 0 0 - -
1–7 (very mild–very severe)
Overall, how severe were your dog’s fits in the past 3 months? 3 2 2 0 0 0 0
Adverse effects of AED 1–5 (strongly agree–strongly disagree)
In the past 3 months, the adverse effects of the medication to control the fits in 
my dog were acceptable
4 3 0 0 0 - -
In the past 3 months, how severe was the following adverse effect: - -
Eating more/would like to eat more 0 1 1 0 0 - -
Gaining weight 0 0 1 0 0 - -
Drinking more 0 1 0 0 0 - -
Urinating more 0 1 0 0 0 - -
Sleeping more than before 0 2 0 0 0 - -
Wobbly/not coordinated when walking 0 1 0 0 0 - -
Restlessness/pacing 0 1 0 0 0 - -
Itchiness or skin rash 0 0 0 0 0 - -
Vomiting 0 1 0 0 0 - -
Diarrhea 0 0 0 0 0 - -
Coughing 0 0 0 0 0 - -
Restrictions on the carer’s life (related to caring for a dog with IE) 1–5 (never–very often)
In the past 3 months, how often did you feel that your dog’s epilepsy caused 
conflict with your work, education, or day-to-day activities?
1 6 0 0 0 - -
In the past 3 months, how often did you feel that your dog’s epilepsy limited 
your social life?
2 4 0 1 0 - -
In the past 3 months, how often did you feel that your dog’s epilepsy limited 
your independence?
2 4 0 1 0 - -
Frustrations over caring for a dog with IE 1–5 (not at all bothersome–extremely bothersome)
My limitations in work, education or day-to-day activities because of my 
dog’s fits
2 2 1 2 0 - -
My social limitations because of my dog’s fits 1 4 1 1 0 - -
Overall, the limitations on my life caring for my epileptic dog 1 3 3 0 0 - -
Owner distaste of AED adverse effects 1–5b (not at all bothersome–extremely bothersome)
How bothersome are the physical effects of the medication on my dog? 4 1 1 0 0 - -
How bothersome are the mental effects of the medication on my dog? 4 1 0 1 0 - -
In the past 3 months, how much did you dislike the following adverse effects: - -
Eating more/would like to eat more 0 1 0 1 0 - -
Gaining weight 0 1 0 1 0 - -
Urinating more 0 0 0 1 0 - -
Sleeping more than before 1 0 0 0 0 - -
Wobbly/not coordinated when walking 0 0 0 1 0 - -
Restlessness/pacing 0 1 0 0 0 - -
Coughing 0 0 0 0 0 - -
Carer anxiety around the seizure event (and its effects on the dog) 1–5 (strongly disagree–strongly agree)
In the last 3 months, I worried about the frequency of the fits in my dog 1 2 0 3 1 - -
In the last 3 months, I worried about the severity of the fits in my dog 1 2 0 4 0 - -
Perceptions of rectal diazepam use 1–5b (never–always)
Have you ever been uncertain when to give rectal diazepam? 0 0 0 2 0 - -
Have you ever been worried how much or how often you are supposed to give 
rectal diazepam 
0 1 0 1 0 - -
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Discussion
Toy Poodle, Chihuahua and Miniature Dachshund were the 
top 3 most frequent breeds diagnosed with IE in our study. 
Although these are popular breeds in Japan, the high ORs 
in Toy Poodles compared to other 2 breeds suggest that this 
breed might have a higher risk of developing IE. Several 
breeds were reported to be over-represented in studies of IE 
from various countries. These include Beagle23,24), Labrador 
Retriever25,26), Golden Retriever3), German Shepherd20,21) and 
Border Terrier20). These breeds were not over-represented in 
our study. This was possibly due to the difference in breed 
population between Western countries and Japan since the 
majority of our patients was small-breed dogs. One descrip-
tive epidemiologic study on IE in dogs, where more than half 
(51.1 %) of the cases were small-breed dogs, reported a high 
prevalence of IE in Toy Poodles27). Therefore, Toy Poodles 
have a potential to be predisposed to IE and can be one of 
a candidate breed to investigate the association between a 
genetic factor and IE. 
There are many studies on canine epilepsy, however, the 
epidemiologic study or data on IE in the literature is less com-
monly available. There is a significant association between 
age of onset and cause of epilepsy in dogs.  In the IVETF 
consensus statement, it is reported that age between 6 months 
and 6 years were more likely to be affected by IE5).  One 
study on epilepsy from Europe reported 4.2 years old as a 
median age of initial seizure in 115 dogs with IE23), which 
is consistent with our current result. However, the median 
age of initial seizure was 2.5 years old in the previous report 
from Japan22). One possible explanation for the younger age 
of initial seizure in the previous report from Japan22) is that 
MRI and CSF analysis were required for the inclusion criteria 
for dogs with the onset of more than 6 years old in this study 
but not in the current study and study from Europe23). The 
criteria in the previous study from Japan22) made it difficult 
to recruit dogs more than 6 years old in age. The percentage 
of male dog (63%) diagnosed with IE was slightly higher 
compared with that of the female dog (37%) in our study. This 
was consistent with several previous reports21-25) indicating 
that male dogs are prone to IE.
The dog that had the episode of CS (57%) and SE (39%) 
was observed in this study. In 2001, it had been reported that 
19 of the 32 (59%) dogs with IE had 1 or more episodes of 
SE25). Dogs that had one or more episodes of SE is slightly 
decreased in our study compared to this previous report25). 
This may be due to the improvement of AEDs in the veteri-
nary field in the past 20 years. Although our results are not 
the general population but population in the referral hospital, 
these data encourage the veterinarians to inform the owners 
about the risk of development of CS and SE in dogs with IE. 
Most of the dogs with the seizure type of GES (92%) and 
FEvG (86%) showed autonomic signs associated with their 
seizures whereas only 30% of the dogs with FES had the 
autonomic sign. Differentiation of epileptic seizure and other 
episodic event are challenging in some situations. In general, 
it is known that autonomic signs are one of the indicators 
to suspect epileptic seizure and our results of generalized 
seizure are consistent with that. However, the differentiation 
of FES and other episodic event remains challenging since 
the autonomic sign was observed in a low population of dogs 
with FES (30%) in this study.
In human medicine, AEDs are selected based on the pa-
tient’s seizure type. However, in dogs, there is no evidence 
for selecting AEDs for specific seizure type. Therefore, 
evaluation of efficacy for specific seizure types in dogs is 
required but it is difficult to perform the study in a single 
institution. To address this problem, IVETF advocated to 
use the evaluation of therapeutic outcome measure in the 
consensus statement in order to draw comparisons among 
institutions3,8). Although the aim of this current study was 
not only evaluation of therapeutic outcome and could not 
evaluate the efficacy for seizure types, we utilized the evalu-
ation of therapeutic outcome measure according to the IVETF 
consensus statement and our data enabled to be utilized in the 
future investigation of evaluating AEDs’ efficacy for specific 
seizure type.
Seizure frequency of fewer than 0.3 times/month is 
reported to be the acceptable for the owners in Europe19). In 
our study, none of the owners answered their dog’s seizure is 
unacceptable or sever. This is indicating that there is a differ-
ence in perception to seizure between the regions. However, 
seizure frequency of more than 0.3 times/month is reported 
as a risk factor to decrease the survival time in dogs with epi-
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lepsy22). Therefore, it is important to inform it to the owners 
especially in Japan. The questionnaire revealed the objective 
data of how the owners are thinking about their dog’s seizure 
and what is the problem for the owners in their treatment of 
their epileptic dogs. Although we cannot conclude with our 
small sample size, it may be said that the questionnaire of 
QOL provides useful data for improving management of the 
epileptic dogs and communicate with their owners.
Conclusions
This study described the clinical data of dogs with IE in 2 
referral centers in Japan. Toy Poodles were over-represented 
in the present study suggesting that this breed can be a good 
candidate for genetic investigation. Since the data acquisi-
tion was performed with an accordance to IVETF consensus 
statement, this study will provide useful data for further 
investigation on IE in dogs.
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